Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$20.60 -0.06 (-0.29%)
2/9/2010 4:00 PM

QIAGEN N.V. (QGEN)

CAPS Rating:
***

The Company is a provider of innovative technologies and products for preanalytical sample preparation and linked molecular assay solutions.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating QGEN

Add Stock to Watchlist

What the Community Thinks

Total Members

105 Outperforms
6 Underperforms
 

All-Stars

39 Outperforms
3 Underperforms
 

Wall Street

5 Outperforms
0 Underperforms
 

Members bullish on QGEN are also bullish on:

Members bearish on QGEN are also bearish on:

Ticker Tags

Growth (1902), Defensive (1457), International Stock (684), Mid Cap (610), Healthcare (711), Genomics (14), Netherlands (15), Life Sciences Tools and Services (53)
Suggest a tag

QIAGEN N.V. At A Glance

Current Price: $20.60
Last Trade Time: 2/9/2010 4:00 PM
Open: $20.68
Previous Close: $20.66
Daily Range: $20.58 - $20.98
52-Week Range: $14.32 - $23.71
Volume: 3,576,071
Market Cap: $4.76B
P/E Ratio: 22.22
Compare Our Special Broker Offers!

Stock Trends

QGEN VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

QIAGEN N.V. (QGEN)

Avatar healthcareinvest (53.26) Submitted: 5/05/08 1:42 PM

A sample and assay technology company with more than 500 consumable products and automated solutions-Netherlands based. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of ...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 11 :   1 2 3 Next »

Recs

0

 (QGEN)

Avatar AHavoc (< 20) Submitted: 7/02/08 10:40 PM : Outperform Start Price: $20.70 QGEN Score: 12.48

Recent introduction of new tools; recent company acquisitions; eps good, relative price strength good; volume and price now pulling above 50 day moving average, looks to grow.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (QGEN)

Avatar healthcareinvest (53.26) Submitted: 5/05/08 1:42 PM : Outperform Start Price: $22.25 QGEN Score: 13.55

A sample and assay technology company with more than 500 consumable products and automated solutions-Netherlands based. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

Products are sold to a diverse customer base, including academic research centers, pharmaceutical and biotechnology companies, molecular diagnostics laboratories as well as to customers in applied testing markets such as forensics, animal or food testing, and pharmaceutical process control.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (QGEN)

Avatar cayamax (< 20) Submitted: 1/17/08 1:29 PM : Outperform Start Price: $21.65 QGEN Score: 12.58

Biomed/Biotech should be one of the good segments in this economy.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (QGEN)

Avatar SaltyGenes (73.42) Submitted: 12/23/07 11:52 AM : Outperform Start Price: $21.81 QGEN Score: 19.37

genetic research will be as all consuming to our children's generation as communications have been to ours. humans are almost as compelled to look into themselves and communicate as they are to eat and mate. cisco anyone?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (QGEN)

Avatar MFClobberMeSilly (57.86) Submitted: 11/09/07 8:27 AM : Outperform Start Price: $21.89 QGEN Score: 17.00

Better than GILD

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 11 :   1 2 3 Next »

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBarclaysCap 94.50 10/08/09 Outperform NS $20.90-1.44%+1.85%-3.29
TrackWedbush 66.12 03/11/09 Outperform NS $16.12+27.79%+49.47%-21.68
TrackJefferies 82.08 03/03/09 Outperform NS $16.07+28.19%+52.49%-24.30
TrackPiperJaff 85.79 10/11/07 Outperform NS $21.16-2.65%-28.47%+25.82
TrackDeutscheSec 89.68 03/22/07 Outperform NS $17.05+20.82%-21.00%+41.82

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 515ms